Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for Problems Getting an Erection

Phase 4CompletedNCT00547352

Eli Lilly and Company160 enrolled

Overview

To determine if men with problems getting and keeping an erection prefer treatment with tadalafil or sildenafil.

Study Type

INTERVENTIONAL

Masking

NONE

Enrollment

160

Conditions

Impotence

Interventions

tadalafilDRUG

20 mg tadalafil tablets taken by mouth, as needed, no more than once a day for 8 weeks.

sildenafilDRUG

Current users of sildenafil citrate for a minimum of 6 weeks prior to visit 1 will continue with an individual dosage to be taken no more than once a day for an additional 4 weeks.

Eligibility

Sex: MALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * History of erection problems * Anticipate a monogamous female sexual relationship * Abstain from other erection treatments throughout the study * Currently use sildenafil Exclusion Criteria: * Other primary sexual disorders * History of radical prostatectomy or other pelvic surgery that affected being able to have an erection * History of penile implant or clinically significant penile deformity. * Nitrate use * Certain heart problems

Locations (1)

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Seoul, South Korea

Outcomes

Primary Outcomes

Patient choice of drug at visit 5

Time frame: 14-15 weeks

Secondary Outcomes

PAIRS self-administered scale scores

Time frame: 14-15 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.